Bristol-Myers Squibb (United States)

875.9k citations
15.5k papers ·

Impact in

  • Oncology top 0.5%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
  • Immunology top 1%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology

Papers in

    • Cancer Immunotherapy and Biomarkers 639
    • CAR-T cell therapy research 446

Bristol-Myers Squibb (United States)

14.2k papers receiving 746.5k citations

Peers

Bristol-Myers Squibb (United States)
Comparison fields: 5 of 245
  • Oncology 203.0k
  • Immunology 133.6k
  • Hepatology 35.1k
  • Pharmaceutical Science 23.5k
  • Hematology 36.7k
Replace Pfizer (United States) with:
Pfizer (United States) United States
Merck & Co., Inc., Rahway, NJ, USA (United States) United States
National Heart, Lung, and Blood Institute United States
United States Food and Drug Administration United States
GlaxoSmithKline (United States) United States
National Institute of Diabetes and Digestive and Kidney Diseases United States
Center for Cancer Research United States
Roswell Park Comprehensive Cancer Center United States
Sidney Kimmel Comprehensive Cancer Center United States
Fox Chase Cancer Center United States
Bristol-Myers Squibb (United States) relative to Pfizer (United States) United States Pfizer (United States)'s profile →
Citations per field
00.5×1.5×2.0×
Pfizer (United States) · 1×
Citations per year

Countries citing scholars working at Bristol-Myers Squibb (United States)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Bristol-Myers Squibb (United States). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Bristol-Myers Squibb (United States) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bristol-Myers Squibb (United States) more than expected).

Fields of papers published by authors at Bristol-Myers Squibb (United States)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Bristol-Myers Squibb (United States) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Bristol-Myers Squibb (United States) at the time of their publication.

About Bristol-Myers Squibb (United States)

In recent decades, authors affiliated with Bristol-Myers Squibb (United States) have published 15.5k papers, which have received a total of 875.9k indexed citations . Scholars at this organization have produced 2.7k papers in Oncology, 944 papers in Hematology, 1.7k papers in Immunology, 469 papers in Pharmaceutical Science and 322 papers in Virology on the topics of Monoclonal and Polyclonal Antibodies Research (809 papers), Cancer Immunotherapy and Biomarkers (639 papers), HIV/AIDS drug development and treatment (587 papers), Protein purification and stability (571 papers), Analytical Chemistry and Chromatography (554 papers), Chemical Synthesis and Analysis (472 papers), CAR-T cell therapy research (446 papers) and Computational Drug Discovery Methods (415 papers). Their work is cited by papers focused on Oncology (203.0k citations), Immunology (133.6k citations), Hepatology (35.1k citations), Pharmaceutical Science (23.5k citations) and Hematology (36.7k citations). Authors at Bristol-Myers Squibb (United States) collaborate with scholars in United States, Germany and United Kingdom and have published in prestigious journals including Bioorganic & Medicinal Chemistry Letters, Blood, Journal of Medicinal Chemistry, Annals of Oncology and Tetrahedron Letters. Some of Bristol-Myers Squibb (United States)'s most productive authors include Nicholas A. Meanwell, Mariano Barbacid, Alejandro A. Aruffo, Peter S. Linsley, Abu T.M. Serajuddin, Jeffrey A. Ledbetter, Rodrigo Bravo, J A Ledbetter, Mohammed Jemal and James F. List.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact